• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION IOL; INTRAOCULAR LENS Back to Search Results
Model Number DFT015
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Macular Edema (1822); Nausea (1970); Uveitis (2122); Visual Impairment (2138); Visual Disturbances (2140)
Date of Event 08/03/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A sample device was not returned for analysis.Complaint history and product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.There have been no other complaints reported in the lot number.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A facility representative reported that following an intraocular lens (iol) implant procedure, the patient experienced the vision problems like blurry vision, poor near and far vision, mild refraction but initiate changes in ocular refraction once to twice a week with multi-diplopia associated with nausea, astigmatism.The patient has got intensive ocular steroid (unknown) treatment.After discontinuation of steroid treatment, patient experienced uveitis.Again the patient started the treatment with steroids but there was no visual improvement.Additional information was received and it was said that, the patient had changing postoperative vision, permanent postoperative inflammation, inflammatory uveitis and glaucoma was ruled out and final diagnosis mentioned as cystoid macular edema.The patient has got the medical treatment with topical anti-inflammatories and oral non steroidal and topical steroid.The patient was recovering from the uveitis.There are two medical device reports associated with this patient.This report is associated with the left eye.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ VIVITY EXTENDED VISION IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
MDR Report Key12365468
Report Number1119421-2021-01630
Device Sequence Number17128352
Product Code POE
UDI-Device Identifier00380652421300
UDI-Public00380652421300
Combination Product (Y/N)N
Initial Reporter CountryCO
PMA/510(K) Number
P930014
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Reporter Type Manufacturer
Report Source foreign
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 08/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/03/2026
Device Model NumberDFT015
Device Lot Number15124359
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/06/2021
Initial Report FDA Received Date08/25/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient Age68 YR
-
-